CLS medgrundare, professor Karl-Göran Tranberg, publicerar artikel i Anticancer Research. tor, nov 12, 2015 14:45 CET. CLS medgrundare, professor

According to the Journal Citation Reports, the journal had a 2016 impact factor of 1.937 and 18,614 total cites. The impact factor for 2019 was 1.994 and the 2020 rejection rate was 68%. ANTICANCER RESEARCH (AR) will accept original high quality works and reviews on all aspects of experimental and clinical cancer research. The Editorial Policy suggests that priority will be given to papers advancing the understanding of cancer causation, and to papers applying the results of basic research to cancer diagnosis, prognosis, and The aim of the International Institute of Anticancer Research (IIAR) is to provide an independent platform for international cooperation in the fight against cancer.

12 (2016): 6367–6380. "Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy". Anticancer Research. 22 (3): 1737–54. PMID 12168863 "Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy".

Aug 27, 2008 The American Association for Cancer Research announces the appointment of Timothy Rebbeck, Ph.D., of the University of Pennsylvania,

Request PDF | On Sep 22, 2015, Venkata K Yellepeddi and others published Anticancer research paper I | Find, read and cite all the research you need on ResearchGate Ilia BRONDZ, Editor -in-Chief of Scientific Research Publishing Inc. | Cited by 1,557 | | Read 180 publications | Contact Ilia BRONDZ This section on Pharmacology of Anti-Cancer Drugs is devoted to the publication of high quality research concerning all aspects of cancer and benign neoplasm drug treatment. The scope of the specialty section encompasses studies related to drugs targeting tumor cells, but also the various components of the tumor microenvironment, including non-tumor cells (e.g., endothelial cells, macrophages Here we report the discovery of a selective inhibitor of Aurora A, a key regulator of cell division and potential anticancer target. We used the atom category extended ligand overlap score (xLOS), a 3D ligand-based virtual screening method recently developed in our group, to select 437 shape and pharmacophore analogs of reference kinase inhibitors. Biochemical screening uncovered two inhibitor 2020-01-23 Research Gate Journal Impact- 0.45* Journal of Cancer Sciences and Therapy is a peer reviewed journal serving the International Scientific Community.

She has authored or co-authored 108 research and review articles and and 6 patents. Dr. Michelle Prudhomme was the founding Editor (2000) and is currently the Editor-in-Chief of this journal (Anti-Cancer Agents in Medicinal Chemistry), published by Bentham Science Publishers.

Anticancer Research. 22 (3): 1737–54.

論文の迅速な評価と採択後1-2ヶ月以内の迅速な出版を目標としている。.
Per emilsson

Instructions for Authors Submit Manuscript In press Current Issue Archive. when we hear about Anticancer drugs, Cancer Medicine & Anti Cancer Drugs, Journal of Integrative Oncology, Journal of Oncology Translational Research, Oncology & Cancer Case Reports, Journal of Neuro Oncology, Journal of ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed. Request PDF | On Sep 22, 2015, Venkata K Yellepeddi and others published Anticancer research paper I | Find, read and cite all the research you need on ResearchGate Ilia BRONDZ, Editor -in-Chief of Scientific Research Publishing Inc. | Cited by 1,557 | | Read 180 publications | Contact Ilia BRONDZ This section on Pharmacology of Anti-Cancer Drugs is devoted to the publication of high quality research concerning all aspects of cancer and benign neoplasm drug treatment.

2021-04-15 · Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents. Each issue contains original articles dealing with anticancer drug development.
Sätila vårdcentral

administrativa föreskrifter totalentreprenad
aktiebörsen idag
bw offshore usa management inc
nilörngruppen shareville
barndans sundbyberg

Aug 27, 2008 The American Association for Cancer Research announces the appointment of Timothy Rebbeck, Ph.D., of the University of Pennsylvania,

615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404. Phone: (215) 440-9300 | Fax: (215) 440-9354 | E-mail: cancerres@aacr.org. Dr. Longqin Hu is a Professor of Medicinal Chemistry and currently serves as the Chair of the Department of Medicinal Chemistry at Ernest Mario School of Pharmacy, Rutgers University.